Celadon Pharmaceuticals Plc (AIM:CEL)
London · Delayed Price · Currency is GBP · Price in GBX 13.40
+1.90 (16.52%)
Jul 1, 2025, 7:30 AM GMT+1
Celadon Pharmaceuticals Company Description
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines.
The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders.
Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Celadon Pharmaceuticals Plc
| Country | United Kingdom |
| Founded | 2018 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 27 |
| CEO | James Short |
Contact Details
Address: 71-75 Shelton Street London, WC2H 9JQ United Kingdom | |
| Phone | 44 20 3150 0252 |
| Website | celadonpharma.com |
Stock Details
| Ticker Symbol | CEL |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | GB00BDQYGP38 |
| SIC Code | 6799 |
Key Executives
| Name | Position |
|---|---|
| James Short | Chief Executive Officer |